Kalaris Therapeutics (NASDAQ:KLRS) Stock Rating Raised to “Hold” at Wall Street Zen
Wall Street Zen upgraded shares of Kalaris Therapeutics (NASDAQ:KLRS – Free Report) from a sell rating to a hold rating in a research note published on Saturday,Wall Street Zen reports. Separately, Weiss Ratings cut Kalaris Therapeutics from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, October 22nd. Six […]
1 Nov 08:25 · The Markets Daily